Evidence map›Paper›PMID 40067353›Full record

ArticleClinical and translational science2025

A Tutorial and Use Case Example of the eXtreme Gradient Boosting (XGBoost) Artificial Intelligence Algorithm for Drug Development Applications.

Matthew Wiens, Alissa Verone-Boyle, Nick Henscheid, Jagdeep T Podichetty, Jackson Burton

Abstract read
In one paragraph

Article in Clinical and translational science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Matthew WiensMetrum Research Group, Boston, Massachusetts, USA.
Alissa Verone-BoyleBiogen, Cambridge, Massachusetts, USA.ORCID 0009-0009-4192-7420
Nick HenscheidCritical Path Institute, Tucson, Arizona, USA.
Jagdeep T PodichettyCritical Path Institute, Tucson, Arizona, USA.ORCID 0009-0001-3922-3549
Jackson BurtonBiogen, Cambridge, Massachusetts, USA.ORCID 0000-0002-0910-2041

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Approaches to artificial intelligence and machine learning (AI/ML) continue to advance in the field of drug development. A sound understanding of the underlying concepts and guiding principles of AI/ML implementation is a prerequisite to identifying which AI/ML approach is most appropriate based on the context. This tutorial focuses on the concepts and implementation of the popular eXtreme gradient boosting (XGBoost) algorithm for classification and regression of simple clinical trial-like datasets. Emphasis is placed on relating the underlying concepts to the code implementation. In doing so, the aim is for the reader to gain knowledge about the underlying algorithm and become better versed with how to implement the algorithm functions for relevant clinical drug development questions. In turn, this will provide practical ML experience which can be applied to algorithms and problems beyond the scope of this tutorial.

Indexed as

AlgorithmsArtificial IntelligenceDrug DevelopmentMachine LearningBoosting Machine Learning AlgorithmsClinical Trials as TopicHumansboostingmachine learningquantitative clinical pharmacologyXGBoost

Identifiers

PMID40067353
PMCPMC11895769

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.